DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Antispasmodic

Antispasmodic

  • The Role of Antispasmodics in Managing Irritable Bowel Syndrome

    The Role of Antispasmodics in Managing Irritable Bowel Syndrome

  • Prohibited Substances List

    Prohibited Substances List

  • Psychopharmacological Treatment and Psychological Interventions in Irritable Bowel Syndrome

    Psychopharmacological Treatment and Psychological Interventions in Irritable Bowel Syndrome

  • Cell Biology

    Cell Biology

  • Pharmacological Treatment of Urinary Incontinence

    Pharmacological Treatment of Urinary Incontinence

  • DITROPAN XL (Oxybutynin Chloride)

    DITROPAN XL (Oxybutynin Chloride)

  • Hyoscyamine Sulfate Odtorally Dispersible Tabletsrx Only

    Hyoscyamine Sulfate Odtorally Dispersible Tabletsrx Only

  • Urinary Antispasmodics TCO 02.2018

    Urinary Antispasmodics TCO 02.2018

  • 2021 Equine Prohibited Substances List

    2021 Equine Prohibited Substances List

  • Trospium Chloride: an Update on a Quaternary Anticholinergic for Treatment of Urge Urinary Incontinence

    Trospium Chloride: an Update on a Quaternary Anticholinergic for Treatment of Urge Urinary Incontinence

  • Drugs Used to Manage Urinary Incontinence in Dogs & Cats

    Drugs Used to Manage Urinary Incontinence in Dogs & Cats

  • HYOSCYAMINE SULFATE ORALLY DISINTEGRATING TABLETS 0.125 MG Rx Only

    HYOSCYAMINE SULFATE ORALLY DISINTEGRATING TABLETS 0.125 MG Rx Only

  • Therapeutic Class Review Urinary Antispasmodics

    Therapeutic Class Review Urinary Antispasmodics

  • Clinical Policy: Urinary Antispasmodic Agents Reference Number: OH.PHAR.PPA.63 Effective Date: 01.01.2020 Last Review Date: Line of Business: Medicaid

    Clinical Policy: Urinary Antispasmodic Agents Reference Number: OH.PHAR.PPA.63 Effective Date: 01.01.2020 Last Review Date: Line of Business: Medicaid

  • Pharmacotherapy for Urinary Bladder Dysfunction in Spinal Cord Injury Patients

    Pharmacotherapy for Urinary Bladder Dysfunction in Spinal Cord Injury Patients

  • Drug Utilization and Polypharmacy Among the Elderly: a Survey in Rio De Janeiro City, Brazil

    Drug Utilization and Polypharmacy Among the Elderly: a Survey in Rio De Janeiro City, Brazil

  • Taste Masking of Dicyclomine Hydrochloride by Polymer Carrier System and Formulation of Oral Disintegrating Tablets

    Taste Masking of Dicyclomine Hydrochloride by Polymer Carrier System and Formulation of Oral Disintegrating Tablets

  • Emselex, INN-Darifenacin

    Emselex, INN-Darifenacin

Top View
  • Ditropan XL USPI 20210329 S-038 Clean
  • Which Urinary Antispasmodic Should I Choose?
  • Bentyl (Dicyclomine Hydrochloride)
  • Irritable Bowel Syndrome (IBS): Introduction
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • ANTICHOLINERGIC DRUGS.Pdf
  • Antispasmodic Effect of Hydroalcoholic and Flavonoids Extracts of Dracocephalum Kotschyi on Rabbit Bladder
  • Irritable Bowel Syndrome. Relevance of Antispasmodics
  • Medications Side-Effects Chart
  • CMDP Preferred Drug List
  • Hyoscyamine Sulfate Orally Disintegrating Tablets 0.125 Mg Rx Only
  • Apo-Oxybutynin, Syrup
  • Darifenacin in the Treatment of Overactive Bladder
  • Trospium Chloride Extended-Release Capsules These Highlights Do Not
  • Medication Management for Older Adults
  • IBS-Monograph-2018.Pdf
  • Intravesical Instillation of Oxybutynin Hydrochloride Therapy for Patients
  • Flavoxate: Present and Future


© 2024 Docslib.org    Feedback